<DOC>
	<DOCNO>NCT02248922</DOCNO>
	<brief_summary>The purpose study evaluate lung clearance index ( LCI ) standardize procedure well characterize study set assess feasibility LCI sensitive method force expiratory volume 1 second ( FEV1 ) measure effectiveness antibiotic therapy patient CF age 6 year old mild moderate lung disease .</brief_summary>
	<brief_title>Evaluation Lung Clearance Index Cystic Fibrosis ( CF ) Patients , Infected With P.Aeruginosa</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<criteria>Confirmed diagnosis CF Patients elevate LCI ≥ 7.5 screen Patients FEV1 ≥ 50 % predict screening Use inhale Tobramycin 28 day / regimen past 3 month screen chronic lung Infection Pseudomonas aeruginosa Patients regularly receive one class inhale antipseudomonal antibiotic Patients use oral intravenous antipseudomonal antibiotic within 28 day prior onphase study drug Pregnant nursing ( lactate ) woman Change dose , formulation strength study drug past treatment cycle screen History hearing loss chronic tinnitus Infection Burkholderia cenocepacia complex Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Cystic Fibrosis , Pseudomonas aeruginosa , Lung Clearance Index , Multiple Breath Washout , Inhaled Tobramycin , Inhaled Antibiotics .</keyword>
</DOC>